KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,435,000 | +20.4% | 629,154 | -0.5% | 0.04% | +21.2% |
| Q2 2022 | $2,853,000 | -69.7% | 632,506 | -50.6% | 0.03% | -61.2% |
| Q1 2022 | $9,428,000 | -13.0% | 1,279,295 | -24.1% | 0.08% | -1.2% |
| Q4 2021 | $10,837,000 | +68.9% | 1,685,405 | +52.9% | 0.09% | +72.0% |
| Q3 2021 | $6,416,000 | -58.2% | 1,102,427 | -26.0% | 0.05% | -55.8% |
| Q2 2021 | $15,366,000 | +19.6% | 1,488,939 | +21.9% | 0.11% | +16.5% |
| Q1 2021 | $12,852,000 | -73.5% | 1,221,627 | -60.9% | 0.10% | -72.9% |
| Q4 2020 | $48,415,000 | -10.5% | 3,127,571 | -15.6% | 0.36% | -24.2% |
| Q3 2020 | $54,075,000 | +2.3% | 3,703,786 | +32.7% | 0.47% | +0.9% |
| Q2 2020 | $52,852,000 | +49.6% | 2,790,501 | +51.7% | 0.47% | +17.9% |
| Q1 2020 | $35,336,000 | +80.9% | 1,839,440 | +80.5% | 0.40% | +175.7% |
| Q4 2019 | $19,537,000 | +14.4% | 1,019,138 | -42.6% | 0.14% | +7.5% |
| Q3 2019 | $17,084,000 | +317.7% | 1,775,865 | +160.1% | 0.13% | +332.3% |
| Q2 2019 | $4,090,000 | +2.5% | 682,853 | -0.1% | 0.03% | +10.7% |
| Q1 2019 | $3,991,000 | +156.8% | 683,363 | +311.9% | 0.03% | +115.4% |
| Q4 2018 | $1,554,000 | -55.4% | 165,899 | -18.9% | 0.01% | -40.9% |
| Q3 2018 | $3,484,000 | -33.2% | 204,556 | -33.4% | 0.02% | -40.5% |
| Q2 2018 | $5,217,000 | – | 307,035 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |